Zhang Y, Ji S, Miao G, Du S, Wang H, Yang X
Cancer Biol Med. 2024; 21(9).
PMID: 39177125
PMC: 11414224.
DOI: 10.20892/j.issn.2095-3941.2024.0188.
Poirier N, Paquin V, Leclerc S, Lisi V, Marmolejo C, Affia H
J Immunother Cancer. 2024; 12(5).
PMID: 38754915
PMC: 11097815.
DOI: 10.1136/jitc-2023-008435.
Hato L, Vizcay A, Eguren I, Perez-Gracia J, Rodriguez J, Gallego Perez-Larraya J
Cancers (Basel). 2024; 16(5).
PMID: 38473341
PMC: 10930494.
DOI: 10.3390/cancers16050981.
Hu H, Zhang M
Braz J Med Biol Res. 2024; 57:e13192.
PMID: 38381884
PMC: 10880883.
DOI: 10.1590/1414-431X2023e13192.
Kato K, Arai S, Sato S, Iwabuchi N, Takara T, Tanaka M
Nutrients. 2024; 16(2).
PMID: 38257109
PMC: 10821487.
DOI: 10.3390/nu16020216.
Distinct Immunophenotypic Features in Patients Affected by 22q11.2 Deletion Syndrome with Immune Dysregulation and Infectious Phenotype.
Costagliola G, Legitimo A, Bertini V, Alberio A, Valetto A, Consolini R
J Clin Med. 2023; 12(24).
PMID: 38137647
PMC: 10743584.
DOI: 10.3390/jcm12247579.
Plasmacytoid dendritic cells contribute to vascular endothelial dysfunction in type 2 diabetes.
Alluri K, Srinivas B, Belmadani S, Matrougui K
Front Cardiovasc Med. 2023; 10:1222243.
PMID: 38094119
PMC: 10716216.
DOI: 10.3389/fcvm.2023.1222243.
T Lymphoblastic Lymphoma Hiding in Mature Plasmacytoid Dendritic Cell Proliferation: A Case Report and Literature Review.
Deng C, Gao B, Wang T, Chang X, Xiao G, Xia Q
Diagnostics (Basel). 2023; 13(20).
PMID: 37892069
PMC: 10605829.
DOI: 10.3390/diagnostics13203248.
Therapies Targeting Immune Cells in Tumor Microenvironment for Non-Small Cell Lung Cancer.
Ye W, Li M, Luo K
Pharmaceutics. 2023; 15(7).
PMID: 37513975
PMC: 10384189.
DOI: 10.3390/pharmaceutics15071788.
Contribution of immune cells to bone metastasis pathogenesis.
He N, Jiang J
Front Endocrinol (Lausanne). 2022; 13:1019864.
PMID: 36246916
PMC: 9556850.
DOI: 10.3389/fendo.2022.1019864.
Interplay between plasmacytoid dendritic cells and tumor-specific T cells in peripheral blood influences long-term survival in non-small cell lung carcinoma.
Laheurte C, Seffar E, Gravelin E, Lecuelle J, Renaudin A, Boullerot L
Cancer Immunol Immunother. 2022; 72(3):579-589.
PMID: 35989364
PMC: 10992197.
DOI: 10.1007/s00262-022-03271-9.
Plasmacytoid dendritic cells during COVID-19: Ally or adversary?.
Van der Sluis R, Holm C, Jakobsen M
Cell Rep. 2022; 40(4):111148.
PMID: 35858624
PMC: 9279298.
DOI: 10.1016/j.celrep.2022.111148.
Monitoring Pre- and Post-Operative Immune Alterations in Patients With Locoregional Colorectal Cancer Who Underwent Laparoscopy by Single-Cell Mass Cytometry.
Zhou C, Wang Z, Jiang B, Di J, Su X
Front Immunol. 2022; 13:807539.
PMID: 35185893
PMC: 8850468.
DOI: 10.3389/fimmu.2022.807539.
Vascular endotheliitis associated with infections: Its pathogenetic role and therapeutic implication.
Hattori Y, Hattori K, Machida T, Matsuda N
Biochem Pharmacol. 2022; 197:114909.
PMID: 35021044
PMC: 8743392.
DOI: 10.1016/j.bcp.2022.114909.
Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation?.
Ligotti M, Pojero F, Accardi G, Aiello A, Caruso C, Duro G
Front Cell Dev Biol. 2021; 9:725606.
PMID: 34595175
PMC: 8477205.
DOI: 10.3389/fcell.2021.725606.
IgG-Complexed Adenoviruses Induce Human Plasmacytoid Dendritic Cell Activation and Apoptosis.
Tran T, Tran T, Kremer E
Viruses. 2021; 13(9).
PMID: 34578281
PMC: 8472521.
DOI: 10.3390/v13091699.
Activation of plasmacytoid dendritic cells promotes AML-cell fratricide.
Fatehchand K, Mehta P, Colvin C, Buteyn N, Santhanam R, Merchand-Reyes G
Oncotarget. 2021; 12(9):878-890.
PMID: 33953842
PMC: 8092344.
DOI: 10.18632/oncotarget.27949.
Interaction Networks Converging on Immunosuppressive Roles of Granzyme B: Special Niches Within the Tumor Microenvironment.
Wang W, Zou R, Qiu Y, Liu J, Xin Y, He T
Front Immunol. 2021; 12:670324.
PMID: 33868318
PMC: 8047302.
DOI: 10.3389/fimmu.2021.670324.
Regulation of the Migration of Distinct Dendritic Cell Subsets.
Feng M, Zhou S, Yu Y, Su Q, Li X, Lin W
Front Cell Dev Biol. 2021; 9:635221.
PMID: 33681216
PMC: 7933215.
DOI: 10.3389/fcell.2021.635221.
Engineering a Human Plasmacytoid Dendritic Cell-Based Vaccine to Prime and Expand Multispecific Viral and Tumor Antigen-Specific T-Cells.
Lenogue K, Walencik A, Laulagnier K, Molens J, Benlalam H, Dreno B
Vaccines (Basel). 2021; 9(2).
PMID: 33578850
PMC: 7916617.
DOI: 10.3390/vaccines9020141.